Vice President Drug Development Consulting · Novotech · company speakers →
Scott is a strategic and innovative drug development executive with 30 years experience across the biopharma, CRO, and non-profit sectors. Passionate about ensuring the patient voice is incorporated into drug development, Scott is focused on patient-focused innovations that reduce the burden of clinical trial. With a particular focus on rare diseases, Scott has built partnerships and collaborations that have led to the acceleration of drug development for rare disease patients. He received a Master’s Degree in Public Health in Biostatistics from the University of Utah School of Medicine and completed a Graduate Research Fellowship at The National Institutes of Health/NINDS.
Is this you? Claim this profile →
No public contact links on file.
Sectors
Sourcing speakers for your event?
Browse the speaker directory →